Skip to main content
SpringerLink
Log in

Eine neue Ära in der Therapie des Glioblastoms

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011–1018

    Article  CAS  PubMed  Google Scholar 

  2. Lohr F, Wenz F (2003) Glioblastome. In: Lohr F, Wenz F. Strahlentherapie kompakt. Urban und Fischer, München, S 166–169

  3. Wick W et al. (2002) Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage for focal adhesion kinase. Cancer Res 62:1915–1919

    CAS  PubMed  Google Scholar 

  4. Chinot OL et al. (2004) Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100:2208–2214

    Article  CAS  PubMed  Google Scholar 

  5. DeAngelis LM (2005) Chemotherapy for brain tumors – A new beginning. New Engl J Med 352:1036–1038

    Article  CAS  PubMed  Google Scholar 

  6. Blan JL et al. (2004) Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. J Neurooncol 68:275–283

    Article  CAS  PubMed  Google Scholar 

  7. Wasserfallen JB et al. (2004) Can we afford to add chemotherapy to radiotherapy for glioblastoma mutiforme? Cost-identification analysis of concomoittant and adjuvant treatment with temozolomide until patient death. Cancer 101:2098–2105

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Strahlentherapie, Universität Regensburg

    C. Schäfer Master of Bioethics & O. Kölbl

  2. Klinik und Poliklinik für Strahlentherapie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053 , Regensburg

    C. Schäfer Master of Bioethics

Authors
  1. C. Schäfer Master of Bioethics
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Kölbl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Schäfer Master of Bioethics.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schäfer, C., Kölbl, O. Eine neue Ära in der Therapie des Glioblastoms. Onkologe 11, 689–691 (2005). https://doi.org/10.1007/s00761-005-0891-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-005-0891-8

Search

Navigation